MyndTec (MYTC.CN) Action Cours

MyndTec, Inc. engages in the research, development, and distribution of therapies for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The company is headquartered in Mississauga, Ontario. The company went IPO on 2022-02-24. The firm researches, develops and distributes therapies designed to improve function, maximize independence and enhance the quality of life for individuals with paralysis due to stroke or spinal cord injury. The company develops non-invasive neuro and nervous system electrical stimulation therapeutics for the treatment of neurological diseases specifically targeted to markets with large, growing, global patient populations. Its first product and flagship solution, MyndMove therapy, is a functional electrical stimulator coupled with proprietary treatment protocols that integrates neuro stimulation with a cloud-connected database. MyndMove applies advanced principles of neuroplasticity and functional electrical stimulation to assist patients with paralysis of the arm and hand to make lasting gains in the recovery of natural, voluntary movement. The company sells MyndMove directly to clinics and institutions. MyndStep is a foot drop device.